Alternative Medicines Corner

Back to articles

FDA Backtracks on Ephedra Dosing, Duration Warnings

KEY POINT

Proposed limitations on the amount of ephedra allowed in dietary supplements and recommendations on lengths of therapy will be withdrawn, FDA has told Congress. With political pressure against it, federal courts limiting its authority, and scientific evidence lacking, the agency decided to instead compile and release information on adverse events associated with the natural product, the source of ephedrine.